Abstract
Background: The pathogenesis of Parkinson’s disease (PD) is not fully understood. Together with some important physiological functions in the Central Nervous System (CNS), nitric oxide (NO) can have both, neuroprotective or neurotoxic actions, depending on its redox state. An important body of evidence suggests the involvement of NO in many of the processes leading to neurodegeneration in several neurological disorders including PD. Objective: The main aim of this review is to update the data regarding the possible involvement of NO in the pathogenesis of PD. Methods: We performed a literature review on neuropathological, biochemical and genetic studies in PD patients and in several experimental models of parkinsonism and role of NO in these models. Results: Both studies in humans and in experimental models of parkinsonism give support to the contribution of NO in excitotoxicity, inflammation, oxidative stress, mitochondrial function impairment, DNA damage, and Snitrosylation of diverse proteins. The interaction of these mechanisms leads finally to neuronal death. The fact that selective of specific inhibitors of NO synthase (NOS, the enzyme responsible of NO synthesis) should prevent neuronal death through their actions of these pathogenic mechanisms supports the role of NO on PD as well. Conclusion: NO participates in the pathogenesis of PD by multiple mechanisms described in this review.
Keywords: Nitric oxide, nitric oxide synthase, Parkinson’s disease, neurodegeneration, oxidative stress, excitotoxicity, inflammation, S-nitrosylation.
Current Medicinal Chemistry
Title:An Update on the Role of Nitric Oxide in the Neurodegenerative Processes of Parkinson's Disease
Volume: 23 Issue: 24
Author(s): Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, María Trinidad Herrero, Elena García-Martín and José A.G. Agúndez
Affiliation:
Keywords: Nitric oxide, nitric oxide synthase, Parkinson’s disease, neurodegeneration, oxidative stress, excitotoxicity, inflammation, S-nitrosylation.
Abstract: Background: The pathogenesis of Parkinson’s disease (PD) is not fully understood. Together with some important physiological functions in the Central Nervous System (CNS), nitric oxide (NO) can have both, neuroprotective or neurotoxic actions, depending on its redox state. An important body of evidence suggests the involvement of NO in many of the processes leading to neurodegeneration in several neurological disorders including PD. Objective: The main aim of this review is to update the data regarding the possible involvement of NO in the pathogenesis of PD. Methods: We performed a literature review on neuropathological, biochemical and genetic studies in PD patients and in several experimental models of parkinsonism and role of NO in these models. Results: Both studies in humans and in experimental models of parkinsonism give support to the contribution of NO in excitotoxicity, inflammation, oxidative stress, mitochondrial function impairment, DNA damage, and Snitrosylation of diverse proteins. The interaction of these mechanisms leads finally to neuronal death. The fact that selective of specific inhibitors of NO synthase (NOS, the enzyme responsible of NO synthesis) should prevent neuronal death through their actions of these pathogenic mechanisms supports the role of NO on PD as well. Conclusion: NO participates in the pathogenesis of PD by multiple mechanisms described in this review.
Export Options
About this article
Cite this article as:
Jiménez-Jiménez Javier Félix, Alonso-Navarro Hortensia, Herrero Trinidad María, García-Martín Elena and Agúndez A.G. José, An Update on the Role of Nitric Oxide in the Neurodegenerative Processes of Parkinson's Disease, Current Medicinal Chemistry 2016; 23 (24) . https://dx.doi.org/10.2174/0929867323666160812151356
DOI https://dx.doi.org/10.2174/0929867323666160812151356 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Overview on the Importance of Combining Complementary Analytical Platforms in Metabolomic Research
Current Topics in Medicinal Chemistry Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Mitochondrial Effects of Organoselenium and Organotellurium Compounds
Current Organic Chemistry A Palliative Care Approach to the Advanced Heart Failure Patient
Current Cardiology Reviews Studying the Effects of Classic Hallucinogens in the Treatment of Alcoholism: Rationale, Methodology, and Current Research with Psilocybin
Current Drug Abuse Reviews NS5A - From Obscurity to New Target for HCV Therapy
Recent Patents on Anti-Infective Drug Discovery Risk Factors for Cardiovascular Disease in Psoriasis: Relation to Inflammation Assessed by the Severity and Duration of Illness
Inflammation & Allergy - Drug Targets (Discontinued) Meet Our Editorial Board Member
Medicinal Chemistry Validity of Alcohol Screening Instruments in General Population Gender Studies: An Analytical Review
Current Drug Abuse Reviews Structure-Based Rational Design of Adenosine Receptor Ligands
Current Topics in Medicinal Chemistry Characterization of HBV Among HBV/HIV-1 Co-Infected Injecting Drug Users from Mombasa, Kenya
Current HIV Research B Cells: Programmers of CD4 T Cell Responses
Infectious Disorders - Drug Targets Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Current Pharmaceutical Design Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Histamine H3 Receptor: A Potential Drug Target for the Treatment of Central Nervous System Disorders
Current Drug Targets - CNS & Neurological Disorders Whole Milk and Full-Fat Dairy Products and Hypertensive Risks
Current Hypertension Reviews Use and Results of Antidepressant Treatment: Patients' Perception
Current Drug Therapy Editorial (Thematic Issue: Playing Well with Others! Initiating and Sustaining Successful Collaborations between Industry, Academia and Government)
Current Topics in Medicinal Chemistry Drugs for AIDS
Mini-Reviews in Medicinal Chemistry RNA G-Quadruplexes: G-quadruplexes with “U” Turns
Current Pharmaceutical Design